Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170038/S032

CentriMag Circulatory Support System

Abbott · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONP170038/S032

What did the FDA decide?

The FDA record for P170038/S032 describes a 30-day notice under the CentriMag Circulatory Support System PMA, with the stated purpose of replacing existing wave soldering equipment with new wave soldering equipment. The listed supplement reason is a process change involving a manufacturer, sterilizer, packager, or supplier. The device category is ventricular (assist) bypass, specialty cardiovascular, product code DSQ, applicant Abbott.

The identifier establishes this as a supplement to PMA P170038 rather than a new approval of the whole system, and it is a manufacturing notice rather than an original PMA. The statement does not name the affected facility, equipment model, process controls, or validation data, and it does not say whether soldering affects a patient-contacting component. The reported purpose is not evidence of safety or clinical effectiveness, and the record gives no basis for a new indication or clinical use.

FDA approval order statement

replacement of the existing wave soldering equipment with new wave soldering equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 2, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170038/S032
Regulatory pathway
PMA supplement
Applicant
Abbott
Product code
DSQ
Decision code
OK30
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Abbott
Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170038 · Original PMA

    CentriMag Circulatory Support System

  2. P170038/S032 received

    Application receipt date recorded by FDA.

  3. P170038/S032 · FDA decision

    30-Day Notice

  4. P170038/S033 · Related supplement

    CentriMag Circulatory Support System

  5. P170038/S034 · Related supplement

    CentriMag Circulatory Support System

Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170038

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA approvalDec 6, 2019FDA
AbbottPMA supplementOct 2, 2026FDA
AbbottPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records